Suntar Eco-City Limited

BKZ

SG1CC1000007

Pharmaceuticals

Market Closed - Singapore S.E. Other stock markets 07:47:13 26/04/2024 BST			5-day change	1st Jan Change
0.08 ^SGD	-22.33%		-.--%	-2.44%

04-29	Suntar Eco-City Limited Announces Board Changes	CI
04-11	Suntar Eco-City Limited Announces Management Changes	CI

Suntar Eco-City Limited Reports Earnings Results for the Full Year Ended December 31, 2020

February 26, 2021 at 09:36 am

Suntar Eco-City Limited announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was RMB 22.204 million compared to RMB 3.250 million a year ago. Net income was RMB 436,000 compared to RMB 26,000 a year ago.

Latest news about Suntar Eco-City Limited

Suntar Eco-City Limited Announces Board Changes	04-29	CI
Suntar Eco-City Limited Announces Management Changes	04-11	CI
Suntar Eco-City Limited Announces Appointment of Hu Yugan as Lead Independent Director, Chairman of the Audit Committee, and A Member of the Nominating Committee and the Remuneration Committee, Effective 1 May 2024	04-11	CI
Suntar Eco-City Swings to Attributable Loss in H2 2023 Despite Surge in Revenue	02-29	MT
Suntar Eco-City Limited Reports Earnings Results for the Full Year Ended December 31, 2023	02-28	CI
Suntar Eco-City Limited Appoints Ms Sharon Lim Siew Choo as Company Secretary in Place of Ms Shirley Tan Sey Liy	11-15	CI
Suntar Eco-City Limited Reports Earnings Results for the Half Year Ended June 30, 2023	14/08/23	CI
Suntar Eco-City Limited Reports Earnings Results for the Full Year Ended December 31, 2022	28/02/23	CI
Suntar Eco-City Limited Reports Earnings Results for the Half Year Ended June 30, 2022	12/08/22	CI
Suntar Eco-City Limited Reports Earnings Results for the Full Year Ended December 31, 2021	01/03/22	CI
Suntar Eco-City's Indirect Associate Exercises Option to Purchase Property in China	03/01/22	MT
Suntar Eco-City Unit Forms Property Development Subsidiary in China	29/12/21	MT
Suntar Eco-City Limited Announces Change of Registered Office Address	29/10/21	CI
Suntar Eco City : Unit Acquires 51% Stake in Bottled Drinking Water Manufacturer	13/08/21	MT
Suntar Eco-City Limited Reports Earnings Results for the Half Year Ended June 30, 2021	12/08/21	CI
Suntar Eco-City Limited Announces Company Secretary Changes	26/02/21	CI
Suntar Eco-City Limited Reports Earnings Results for the Full Year Ended December 31, 2020	26/02/21	CI
Suntar Eco City : Unit to Sell Subsidiary	23/02/21	MT
Suntar Eco-City Limited Reports Earnings Results for the Half Year Ended June 30, 2020	13/08/20	CI
Suntar Eco-City Limited Appoints Fiona Lim Pei Pei as Company Secretary	19/03/20	CI
Suntar Eco-City Limited Announces Change of Registered Office	18/03/20	CI
Suntar Eco-City Limited Reports Earnings Results for the Full Year Ended December 31, 2019	28/02/20	CI
Suntar Eco-City Limited Reports Earnings Results for the Third Quarter Ended September 30, 2019	13/11/19	CI
Suntar Eco-City Limited Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2019	14/08/19	CI
Suntar Eco-City Limited Appoints Pan Shimo as an Non-Executive Independent Director	25/07/19	CI

Chart Suntar Eco-City Limited

Duration

Period

More charts

Company Profile

Suntar Eco-City Limited is a Singapore-based investment holding company. The Company operates through two segments: Health & Nutrition, and Property Development. The Health and nutrition segment products deals in sales of health and nutrition products to distributors in the China domestic market. The Property Development segment is engaged in the business of sales of properties to individual buyers in the China domestic market. The Companyâs subsidiaries include China Green Eco-Holdings Pte Ltd, and Xiâan Suntar Eco-city Co., Ltd.

Sector

Pharmaceuticals

Calendar

14/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
SUNTAR ECO-CITY LIMITED	-2.44%	3.71M
MCKESSON CORPORATION	+20.94%	72.78B
CARDINAL HEALTH, INC.	-1.26%	24.24B
SINOPHARM GROUP CO. LTD.	+5.13%	8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+8.25%	8.38B
HUADONG MEDICINE CO., LTD	-19.42%	8.09B
H. LUNDBECK A/S	+5.56%	4.81B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+16.83%	4.32B
EBOS GROUP LIMITED	-1.83%	4.05B
GALENICA AG	-1.65%	3.93B